Business Description
Luoxin Pharmaceuticals Group Stock Co Ltd
ISIN : CNE1000026S7
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.9 | |||||
Debt-to-EBITDA | -3.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.2 | |||||
Beneish M-Score | -3.58 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.5 | |||||
3-Year Book Growth Rate | -6.2 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.23 | |||||
9-Day RSI | 47.19 | |||||
14-Day RSI | 47.94 | |||||
6-1 Month Momentum % | -2.44 | |||||
12-1 Month Momentum % | -19.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 132.22 | |||||
Days Sales Outstanding | 77.6 | |||||
Days Payable | 111.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 9.5 | |||||
Shareholder Yield % | 18.28 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.89 | |||||
Operating Margin % | -16.53 | |||||
Net Margin % | -28.82 | |||||
FCF Margin % | -7.68 | |||||
ROE % | -28.7 | |||||
ROA % | -13.28 | |||||
ROIC % | -10.68 | |||||
ROC (Joel Greenblatt) % | -28.46 | |||||
ROCE % | -19.58 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 13.9 | |||||
PS Ratio | 1.88 | |||||
PB Ratio | 2.22 | |||||
Price-to-Tangible-Book | 3.42 | |||||
EV-to-EBIT | -10.03 | |||||
EV-to-EBITDA | -10.03 | |||||
EV-to-Revenue | 2.44 | |||||
EV-to-FCF | -31.46 | |||||
Earnings Yield (Greenblatt) % | -9.97 | |||||
FCF Yield % | -3.96 | |||||
Forward Rate of Return (Yacktman) % | -19.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Luoxin Pharmaceuticals Group Stock Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,418.28 | ||
EPS (TTM) (Â¥) | -0.65 | ||
Beta | 1.26 | ||
Volatility % | 44.67 | ||
14-Day RSI | 47.94 | ||
14-Day ATR (Â¥) | 0.196847 | ||
20-Day SMA (Â¥) | 4.4035 | ||
12-1 Month Momentum % | -19.6 | ||
52-Week Range (Â¥) | 3.22 - 5.98 | ||
Shares Outstanding (Mil) | 1,087.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Luoxin Pharmaceuticals Group Stock Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Luoxin Pharmaceuticals Group Stock Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Luoxin Pharmaceuticals Group Stock Co Ltd Frequently Asked Questions
What is Luoxin Pharmaceuticals Group Stock Co Ltd(SZSE:002793)'s stock price today?
When is next earnings date of Luoxin Pharmaceuticals Group Stock Co Ltd(SZSE:002793)?
Does Luoxin Pharmaceuticals Group Stock Co Ltd(SZSE:002793) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |